Novartis Investigative Site

Losser 7581 BV

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, Hypertension, Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early